Wellington Management Group
FMTX

Wellington Management Group’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Wellington Management Group’s Portfolio FMTX Stock Details FMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-280,183
Closed -$5.59M – 2194
2022
Q3 		$5.59M Buy
280,183
+191,002
+214% +$2.52M ﹤0.01% 1251
2022
Q2 		$614K Hold
89,181
– – ﹤0.01% 1779
2022
Q1 		$830K Buy
89,181
+38,318
+75% +$408K ﹤0.01% 1771
2021
Q4 		$723K Buy
+50,863
New +$880K ﹤0.01% 1865
2021
Q3 		– Sell
-213,044
Closed -$5.3M – 2313
2021
Q2 		$5.3M Sell
213,044
-156,596
-42% -$4.21M ﹤0.01% 1492
2021
Q1 		$10.4M Sell
369,640
-1,126,606
-75% -$40.6M ﹤0.01% 1232
2020
Q4 		$52.2M Sell
1,496,246
-346,365
-19% -$15.1M 0.01% 753
2020
Q3 		$90.5M Sell
1,842,611
-332,502
-15% -$13.4M 0.02% 543
2020
Q2 		$98.4M Buy
+2,175,113
New +$94.3M 0.02% 527

Wellington Management Group's FMTX Position: Q4 2022 in Review

Wellington Management Group sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 280,183 shares — an estimated $5.59M sold.

Wellington Management Group first reported a position in FMTX in Q2 2020 and held it in 9 quarters. The position peaked at $98.4M in Q2 2020. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

  • Wellington Management Group reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Wellington Management Group sold 280,183 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $5.59M.
  • Wellington Management Group first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q2 2020 and held it in 9 quarters.
  • Wellington Management Group's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $98.4M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Wellington Management Group's 13F filing for Q4 2022, filed 13 Feb 2023.